简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-05-23 09:00 LKKHPG Named One of the Best Companies to Work for in Asia
2016-05-18 17:30 Global Food & Beverage Companies Commit to Trans Fat Phase-Out Worldwide
2016-05-18 10:02 South Korea is first to approve next generation lung cancer treatment olmutinib (BI 1482694 / HM61713)
2016-05-17 15:19 New Presentations at ATS 2016 Reinforce OFEV® (nintedanib) Efficacy, Safety and Tolerability Across Broad Range of Patients with IPF
2016-05-17 10:28 IPV Capital and Tsing Capital Lead $26 Million Investment in RayVio
2016-05-13 17:21 Takeda Reports Results for Fiscal Year 2015 (April 2015 – March 2016) and Forecast for Fiscal Year 2016
2016-05-13 13:53 Takeda Appoints New Chief Financial Officer, James Kehoe
2016-05-12 10:11 Pradaxa®: First NOAC to be assessed in prospective study in patients with blood clots in the veins or venous sinuses of the brain
2016-05-11 15:26 Boehringer Ingelheim: Nine out of 10 AF patients are concerned about stroke and many want to be part of OAC treatment decisions, new international survey shows
2016-05-11 15:08 Incyte and ARIAD Announce Agreement for Incyte to Acquire ARIAD’s European Operations and In-license Iclusig® (ponatinib) in Europe
2016-05-11 14:33 JHL Biotech Opens Innovative Biosimilars Manufacturing Facility in China
2016-05-10 14:50 Takeda Receives $38 Million Grant from the Bill & Melinda Gates Foundation to Support Polio Eradication in Developing Countries
2016-05-09 15:28 LUME-Meso trial enrols first patient: Boehringer Ingelheim’s new pivotal study investigating nintedanib for the treatment of malignant pleural mesothelioma
2016-05-06 17:37 IMS Health and Quintiles to Merge
2016-05-04 16:59 22nd Century Group to Utilize Revolutionary New Filter Technology from Strategic Supplier, Celanese Corporation
2016-05-04 10:00 First-Ever Published Study Proves House Wellness Foods’ Feed LP20® Increases Immunity, Productivity of Whiteleg shrimp [L. vannamei]
2016-05-03 13:42 Ora® Appoints David Hollander, M.D., M.B.A., as Chief Medical Officer
2016-05-03 09:46 The Revolutionary Intraocular Lens – InFo Instant Focus© – Now Available with an Extended Power Range
2016-04-29 11:11 Phase 3 Trial Results for First Oral Proteasome Inhibitor NINLARO (ixazomib) Published in The New England Journal of Medicine
2016-04-28 16:46 Little Life Hack, “Berry” Big Benefit

Business Wire Weibo

Press Releases

Latest Releases